Filing Flows › Health Care › Lumexa Imaging Holdings (LMRI)
Lumexa Imaging Holdings (LMRI) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 13, 2026 · Lumexa Imaging Holdings (LMRI) Q2 2026 earnings results →
Q2 2026 Revenue up 5% year over year to $264M · 1¢ of every $1 of revenue kept as net profit · operating margin 8.7%
Lumexa Imaging Holdings made $264M in Q2 2026 (+5% Y/Y): Health Care Patient Service $195M, Management Fee and Other Revenue Related Party $51.7M, Patient Service Revenue Related Party $8.8M. Operating margin 8.7%, net earnings $2.7M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 13, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $264.2M in Q2 2026, up 5% year over year and up 5% from the previous quarter. Health Care Patient Service was the largest line at 74% of revenue. Health Care Patient Service added $5.6M year over year (up 3%), 44% of the total change.
Operating profit was $23.0M, a 8.7% margin (down 2.3 points year over year). Operating profit fell $4.6M even though revenue rose $12.8M versus a year earlier, so costs grew faster than sales. Total costs grew 8% against revenue growth of 5%. The fastest-growing cost line was General & admin (+31%). Net earnings were $2.7M. The effective tax rate was 52.4%.
Operating cash flow was $32.8M (up 1482% year over year), 1195% of net earnings. Non-cash charges added back $10.1M of depreciation and amortization and $12.7M of share-based compensation. Working capital and other items added $7.2M. Capital expenditures of $9.7M left free cash flow of $23.1M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 13, 2026 | $264M | +5% | 8.7% | $2.7M | $32.8M |
| Q1 2026 | 10-Q | May 12, 2026 | $253M | +3% | 7.7% | $1.7M | $2.9M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Lumexa Imaging Holdings
Lumexa Imaging is a nationwide provider of outpatient medical imaging. With over 5,000 team members and greater than 190 outpatient imaging centers, our team conducted approximately 4 million outpatient procedures system-wide in 2025. We are a partner of choice for health systems and radiologists, delivering best-in-class clinical excellence, operations, and state-of-the-art technology across our platform.
In its own words, from its 8-K, filed Aug 12, 2026.
Lumexa Imaging Holdings against its Services-Medical Laboratories peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +5% against the peers' median +15%. Operating margin: 8.7% against the peers' median 7.0%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| LMRI Lumexa Imaging Holdings | Q2 2026 | $264M | +5% | 8.7% |
| LH Labcorp Holdings | Q3 2026 | $3.8B | +7% | 10.6% |
| DGX Quest Diagnostics | Q3 2026 | $3.1B | +10% | 15.5% |
| NTRA Natera | Q3 2026 | $794M | +34% | -8.6% |
| FTRE Fortrea Holdings | Q3 2026 | $692M | -1% | 2.2% |
| RDNT RadNet | Q2 2026 | $623M | +25% | 6.3% |
| GH Guardant Health | Q3 2026 | $361M | +36% | -36.8% |
| CAI Caris Life Sciences | Q3 2026 | $275M | +27% | 7.0% |
| VCYT Veracyte | Q3 2026 | $152M | +15% | 10.9% |
Source: Lumexa Imaging Holdings 10-Q on SEC EDGAR · CIK 2071288 · Services-Medical Laboratories
13F: who owns LMRI and who is buying
More on LMRI
History
Every quarter: Q2 2026 results · Q1 2026 results